INSR |
INSR: Insulin receptor precursor |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
4.487 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
4.487 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
KRT18 |
KRT18: Uncharacterized protein KRT18 |
4.487 |
Evidence |
|
GHR |
GHR: Growth hormone receptor precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
4.487 |
Evidence |
|
CDK2 |
CDK2: Cell division protein kinase 2 |
ARHGAP12 |
ARHGAP12: Rho GTPase-activating protein 12 |
4.485 |
Evidence |
|
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
4.485 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
SORBS3 |
SORBS3, SCAM1: Vinexin |
4.485 |
Evidence |
|
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
CCNB1 |
Cyclin B1 |
4.485 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
4.485 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
CD2AP |
CD2AP: CD2-associated protein |
4.485 |
Evidence |
|
RBP4 |
RBP4, PRO2222: Plasma retinol-binding protein precursor |
PON1 |
IPI00555746 |
4.48 |
Evidence |
|
HPN |
HPN, TMPRSS1: Serine protease hepsin |
SLC22A7 |
SLC22A7, RP11-480N24.7-001, hCG_19011: Solute carrier family 22 |
4.48 |
Evidence |
|
HPR |
HPR: Haptoglobin-related protein precursor |
PON1 |
IPI00555746 |
4.48 |
Evidence |
|
RBP4 |
RBP4, PRO2222: Plasma retinol-binding protein precursor |
AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
4.48 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BID |
BID: BH3-interacting domain death agonist |
4.48 |
Evidence |
|
raptor |
RAPTOR, KIAA1303: Regulatory-associated protein of mTOR |
PKP3 |
PKP3: Plakophilin-3 |
4.48 |
Evidence |
|
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
SIGLEC12 |
SIGLEC12, SIGLECL1, UNQ9215/PRO34042, SLG: Sialic acid-binding Ig-like lectin 12 |
4.48 |
Evidence |
|
FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
4.48 |
Evidence |
|
CMA1 |
CMA1, CYH, CYM: Chymase precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
4.48 |
Evidence |
|
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
MKNK2 |
MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 |
4.48 |
Evidence |
|
CHGB |
CHGB, SCG1: Secretogranin-1 precursor |
STAT3 |
|
4.48 |
Evidence |
|
FADD |
FADD, MORT1: Protein FADD |
STAT3 |
|
4.48 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
4.48 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
RAP1GA1 |
IPI00514917 |
4.48 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
4.48 |
Evidence |
|